Industries > Pharma > Global Liquid Biopsy Market Forecast to 2029

Global Liquid Biopsy Market Forecast to 2029

Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres

PUBLISHED: 29 November 2019
PAGES: 180
PRODUCT CODE: PHA0620
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0620 Categories: , Tag:

The global liquid biopsy market is estimated to reach $1,173.5m in 2019. The kits & reagents submarket holds the biggest share of the global liquid biopsy market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 180-page report you will receive 179 charts– all unavailable elsewhere.

The 180-page report provides clear detailed insight into the liquid biopsy market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Liquid Biopsy Market forecast to 2029

• Revenue forecasts for the Liquid Biopsy Market Forecast by Product to 2029:
• Instruments
• Kits & Reagents
• Services

Each submarket is further segmented by regional market.

• Revenue forecasts for the Liquid Biopsy Market Forecast by Sample to 2029:
• Blood
• Urine
• Other Samples

Each submarket is further segmented by regional market.

• Revenue forecasts for the Liquid Biopsy Market Forecast by Biomarker to 2029:
• Circulating Tumor Cells (CTC)
• Circulating Tumor DNA (CtDNA)
• Exosomes
• Other Biomarkers

Each submarket is further segmented by regional market.

• Revenue forecasts for the Liquid Biopsy Market Forecast by Cancer to 2029:
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancers

Each submarket is further segmented by regional market.

• Revenue forecasts for the Liquid Biopsy Market Forecast by End-User to 2029:
• Hospitals
• Diagnostic Laboratories
• Academic Institutions
• Cancer Research Centres

Global Liquid Biopsy Market Forecast to 2029

Each submarket is further segmented by regional market.

• Revenue forecasts for the Liquid Biopsy Market Forecast by Region to 2029:

North America:
• U.S.
• Canada
• Mexico

Europe:
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia-Pacific:
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific

LAMEA:
• Brazil
• Turkey
• Venezuela
• Saudi Arabia
• Republic of South Africa
• Rest of LAMEA

• Profiles of the selected leading companies:
• Abbott
• Beckman Coulter
• Biocept, Inc.
• Bio-Rad Laboratories
• Biotime
• Caris Lifesciences
• F. Hoffman-La Roche
• Guardant Health, Inc.
• Illumina, Inc.
• MDxHealth SA
• Menarini Silicon Biosystems, Inc.
• Myriad Genetics, Inc.
• OPKO Health, Inc.
• Qiagen N.V.
• Sysmex Inostics
• Trovagene, Inc.

• This report discusses Drivers, Restraints, Opportunities and Threats of the global liquid biopsy market

• The report also includes a PESTLE Analysis of the Global Liquid Biopsy Market

• Key questions answered by this report:
• How is the Liquid Biopsy market evolving?
• What are the drivers and restraints for the growth of the liquid biopsy market?
• What are the market shares of each segment of the overall liquid biopsy market in 2018?
• How will each liquid biopsy submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each liquid biopsy submarket develop to 2029?
• Which individual therapies will prevail and how will these shifts be responded to?
• What will be the main driver for the overall market to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market by 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Liquid Biopsy Market. You find data, trends and predictions.

Buy our report today Global Liquid Biopsy Market Forecast to 2029: Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Liquid Biopsy Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Global Liquid Biopsy Market Forecast to 2029


Latest Pharma news

“Pharmaceutical Contract Manufacturing market set to grow to $138bn by 2024” says Visiongain report

In recent years, one area of biopharmaceutical manufacturing that has come under increasing interest is ADC manufacturing.

16 January 2020

READ

New Advances in the Wound Care Market

In recent years, with the advent of technology, medical practitioners and manufacturers have made huge strides in the wound care market. As one of today’s leading market research and report firms, Visiongain is committed to providing you the most up-to-date information about this exciting industry. That’s why below we’ve collected some of today’s latest products and technologies for your perusal.  …

14 January 2020

READ

Recent Highs & Lows in the Vaccine Market 

With the emergence of new health technology and advances in vaccines, manufacturers and key stakeholders can position themselves to generate big returns in the coming years. However, getting ahead of the competition will require having the right tools at your disposal, which is why Visiongain is proud to offer extensive vaccine market forecasts, as well as reports from other verticals …

14 January 2020

READ

Current Developments in the Global Dermatology Market Pipeline

New trials from around the world are affecting the global dermatology market on an almost daily basis, providing patients with new drugs and medical practitioners with more innovative treatment technology than ever before. That’s why Visiongain has made it their business to help inform key stakeholders and business owners about the most current changes and emerging trends.  Here are a …

14 January 2020

READ

Categories

Category